Part 8/8:
The CAR-T journey encapsulates both the promise of advanced medical technology and the stark realities of market dynamics. As the treatment continues to develop and evolve, stakeholders must navigate the complexities of manufacturing, patient management, and financial reimbursement to harness its full potential. The next few years will be crucial in determining whether the initial hype translates into long-lasting impact in the fight against cancer.